EGFR sequence variations and real-time quantitative polymerase chain reaction analysis of gene dosage in brain metastases of solid tumors

Cancer Genetics and Cytogenetics

Volumn 173, Issue 1, 2007, Pages 63-67

  Franco Hernandez, Carmen ^a   Martinez Glez, Victor ^a   Arjona, Dolores ^a   de Campos, Jose M ^b   Isla, Alberto ^a   Gutierrez, Manuel ^a   Vaquero, Jesus ^c   Rey, Juan A ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

^c HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; BASE PAIRING; BLADDER CARCINOMA; BRAIN METASTASIS; BREAST CARCINOMA; CARCINOGENESIS; CLINICAL ARTICLE; COLON CARCINOMA; CONTROLLED STUDY; EXON; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE DOSAGE; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; LUNG ADENOCARCINOMA; LUNG CARCINOMA; MALE; MELANOMA; OVARY CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; SOLID TUMOR; UNDIFFERENTIATED CARCINOMA;

ADULT; AGED; AMINO ACID SEQUENCE; BASE SEQUENCE; BRAIN NEOPLASMS; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; GENE DOSAGE; HUMANS; MALE; MIDDLE AGED; MUTAGENESIS, INSERTIONAL; MUTATION; NEOPLASMS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RECEPTOR, EPIDERMAL GROWTH FACTOR; SEQUENCE DELETION;

EID: 33846639545     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2006.09.023     Document Type: Article

References (23)

1. In: Kleihues P., and Cavenee W.K. (Eds). Pathology and genetics of tumors of the nervous system. World Health Organization calssification of tumors. 2nd edition (2000), IARC Press, Lyon
2. Torp S.H., Helseth E., Ryamn L., Stolan S., Dalen A., and Unsgarrd G. Expression of the epidermal growth factor receptor gene in human brain metastases. APMIS 100 (1992) 713-719
3. Nathoo N., Chahlavi A., Barnett G.H., and Toms S.A. Pathobiology of brain metastases. J Clin Pathol 58 (2005) 327-342
4. Petersen I., Hidalgo A., Petersen S., Schlüns K., Schewe C., Pacyna-Gengelbach M., Goeze A., Krebber B., Knösel T., Kaufmann O., Szymas J., and von Deimling A. Chromosomal imbalances in brain metastases of solid tumors. Brain Pathol 10 (2000) 395-401
5. Gonzalez-Gomez P., Bello M.J., Alonso M.E., Amiñoso C., Lopez-Marin I., de Campos J.M., Isla A., Gutierrez M., and Rey J.A. Promoter methylation status of multiple genes in brain metastases of solid tumors. Int J Mol Med 13 (2004) 93-98
6. Lynch T.J., Bell D.W., Sordella R., Gurubhagavatula S., Okimoto R.A., Brannigan B.W., Harris P.L., Haserlat S.M., Supko J.G., Haluska F.G., Louis D.N., Christiani D.C., Settleman J., and Haber D.A. Activating mutations in the epidermal growth factor receptor underlaying responsiveness of non-small-cell lung cancer to Gefitinib. N Engl J Med 350 (2004) 2129-2139
7. Tokumo M., Toyooka S., Kiura K., Shigenatsu H., Tomii K., Aoe M., Ichimura K., Tsuda T., Yano M., Tsukuda K., Tabata M., Ueoka H., Tanimoto M., Date H., Gazdar A.F., and Shimizu N. The relationship between epidermal growth factor receptor mutations and clinicopathologic features in non-small cell lung cancers. Clin Cancer Res 11 (2005) 1167-1173
8. Sirotnak F.M., Zakowski M.F., Miller V.A., Scher H.I., and Kris M.G. Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase. Clin Cancer Res 6 (2000) 4885-4892
9. Roggero E., Giancarla B., Antonella P., and Augusto P. Gefitinib ("Iresa", ZD1839) is active against brain metastases in a 77-year-old patient. J Neuro-Oncol 71 (2005) 277-280
10. Shimato S., Mitsudomi T., Kosaka T., Yatabe Y., Wakabayashi T., Mizuno M., Nakahara N., Hatano H., Natsume A., Ishii D., and Yoshida J. EGFR mutations in patients with brain metastases from lung cancer: association with the efficacy of gefitinib. Neuro-Oncol 8 (2006) 137-144
11. Rey J.A., Bello M.J., Jimenez-Lara A., Vaquero J., Kusaak M.E., de Campos J.M., Sarasa J.L., and Pestaña A. Loss of heterozygosity for distal markers on 22q in human gliomas. Int J Cancer 51 (1992) 703-706
12. Arjona D., Bello M.J., Alonso M.E., Aminoso A., Isla A., de Campos J.M., Sarasa J.L., Gutierrez M., Villalobo A., and Rey J.A. Molecular analysis of the EGFR gene in astrocytic gliomas: mRNA expression, quantitative-PCR analysis of non-homogeneous gene amplification and DNA sequence alterations. Neuropathol Appl Neurobiol 31 (2005) 384-394
13. Bello M.J., de Campos J.M., Vaquero J., Ruiz-Barnes P., Kusak M.E., Sarasa J.L., and Rey J.A. HRAD54 gene and 1p high-resolution deletion-mapping analyses in oligodendrogliomas. Cancer Genet Cytogenet 116 (2000) 142-147
14. Blanquicett C., Johnson M.R., Heslin M., and Diasio R.B. Housekeeping gene variability in normal and carcinomatous colorectal and liver tissues: application in pharmacogenomic gene expression studies. Anal Biochem 303 (2002) 209-214
15. Olayioye M.A., Neve R.M., Lane H.A., and Hynes N.E. The erbB signaling network: receptor heterodimerization in development and cancer. EMBO J 19 (2000) 3159-3167
16. Nicholson R.I., Gee J.M., and Harper M.E. EGFR and cancer prognosis. Eur J Cancer 37 (2001) 9-15
17. Halatsch M.-E., Schmidt U., Behnke-Mursch J., Unterberg A., and Wirtz C.R. Epidermal growth factor receptor inhibition for the treatment of glioblastoma multiforme and other malignant brain tumors. Cancer Treatment Rev 32 (2006) 74-89
18. Malden L.T., Novak U., Kaye A.H., and Burgess A.W. Selective amplification of the cytoplasmic domain of the epidermal growth factor receptor gene in glioblastoma multiforme. Cancer Res 48 (1988) 2711-2714
19. Bello M.J., de Campos J.M., Kusak M.E., Vaquero J., Sarasa J.L., Pestana A., and Rey J.A. Ascertainment of chromosome 7 gains in malignant gliomas by cytogenetic and RFLP analyses. Cancer Genet Cytogenet 72 (1994) 55-58
20. Moroni M., Veronese S., Benvenuti S., Marrapase G., Sartore-Bianchi A., Di Nicolantino F., Gambacorta M., Siena S., and Bardelli A. Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to anti-EGFR treatment in colorectal cancer: a cohort study. Lancet Oncol 6 (2005) 279-286
21. Matsumo S, Takahashi K, Iwakawa R, Matsuno Y, Nakanishi Y, Kohno T, Shimizu E, Yokota J. Frequent EGFR mutations in brain metastases of lung adenocarcinoma. Int J Cancer 2006;119:1491-1494.
22. Yoshida Y., Shibata T., Kokubu A., Tsuta K., Matsuno Y., Kanai Y., Asamura H., Tsuchiya R., and Hirohashi S. Mutations of the epidermal growth factor receptor gene in atypical adenomatous hyperplasia and bronchioloalveolar carcinoma of the lung. Lung Cancer 50 (2005) 1-8
23. Zhang W., Park D.J., Lu B., Yang D.Y., Gordon M., Grshen S., Yun J., Press O.A., Vallböhmer D., Rhodes K., and Lenz H.-J. Epidermal growth factor receptor gene polymorphisms predict pelvic recurrence in patients with rectal cancer treated with chemoradiation. Clinical Cancer Res 11 (2005) 600-605